Thermo Fisher Scientific Inc.
TMO
$459.30
$6.701.48%
NYSE
| 03/28/2026 | 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.26B | 10.11B | 3.55B | 6.39B | 5.95B |
| Total Receivables | 10.89B | 10.57B | 10.53B | 10.04B | 9.82B |
| Inventory | 5.50B | 5.43B | 5.75B | 5.56B | 5.22B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.68B | 2.61B | 2.47B | 2.60B | 2.39B |
| Total Current Assets | 22.32B | 28.71B | 22.30B | 24.58B | 23.38B |
|
|
|||||
| Total Current Assets | 22.32B | 28.71B | 22.30B | 24.58B | 23.38B |
| Net Property, Plant & Equipment | 10.66B | 12.01B | 10.18B | 9.64B | 9.33B |
| Long-term Investments | 55.19B | 49.36B | 49.29B | 47.25B | 46.49B |
| Goodwill | 55.19B | 49.36B | 49.29B | 47.25B | 46.49B |
| Total Other Intangibles | 19.15B | 15.84B | 16.24B | 15.15B | 15.32B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.97B | 3.99B | 5.02B | 4.44B | 4.16B |
| Total Assets | 113.28B | 110.34B | 103.02B | 101.23B | 99.04B |
|
|
|||||
| Total Accounts Payable | 3.34B | 3.62B | 3.12B | 2.98B | 3.05B |
| Total Accrued Expenses | 5.19B | 4.98B | 5.01B | 4.64B | 4.38B |
| Short-term Debt | -- | -- | 500.00M | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.09B | 3.81B | 3.32B | 2.21B | 2.82B |
| Total Finance Division Other Current Liabilities | 2.99B | 2.78B | 2.94B | 2.88B | 2.93B |
| Total Other Current Liabilities | 2.99B | 2.78B | 2.94B | 2.88B | 2.93B |
| Total Current Liabilities | 14.62B | 15.19B | 14.89B | 12.72B | 13.17B |
|
|
|||||
| Total Current Liabilities | 14.62B | 15.19B | 14.89B | 12.72B | 13.17B |
| Long-Term Debt | 39.86B | 35.65B | 31.66B | 32.82B | 31.24B |
| Short-term Debt | -- | -- | 500.00M | -- | -- |
| Capital Leases | 213.00M | 1.40B | 196.00M | 196.00M | 200.00M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.53B | 4.57B | 5.12B | 4.89B | 4.94B |
| Total Liabilities | 61.22B | 56.81B | 51.87B | 50.63B | 49.56B |
|
|
|||||
| Common Stock & APIC | 19.16B | 19.01B | 18.78B | 18.68B | 18.56B |
| Retained Earnings | 60.63B | 59.16B | 57.35B | 55.90B | 54.45B |
| Treasury Stock & Other | -27.86B | -24.76B | -25.11B | -24.07B | -23.61B |
| Total Common Equity | 51.93B | 53.41B | 51.02B | 50.51B | 49.39B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 51.93B | 53.41B | 51.02B | 50.51B | 49.39B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 128.00M | 129.00M | 136.00M | 91.00M | 95.00M |
| Total Equity | 52.06B | 53.54B | 51.15B | 50.60B | 49.49B |
|
|
|||||